Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : FTH1
Therapeutic Area : Hematology
Study Phase : Undisclosed
Sponsor : SRS Life Sciences Pte ltd
Deal Size : Undisclosed
Deal Type : Agreement
Details : The agreement provides SRS exclusive rights for sales, marketing, and distribution of Sidero’s patented biologic iron, BioFeTM, for the management of iron deficiency and related disorders in India and Southeast Asia.
Product Name : BioFe
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
October 13, 2020
Lead Product(s) : FTH1
Therapeutic Area : Hematology
Highest Development Status : Undisclosed
Sponsor : SRS Life Sciences Pte ltd
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Biofe
Therapeutic Area : Hematology
Study Phase : Undisclosed
Sponsor : Hershey Medical Center | National Institute of Diabetes and Digestive and Kidney Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Tolerability of BioFe for Iron Deficiency Management
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 30, 2018
Lead Product(s) : Biofe
Therapeutic Area : Hematology
Highest Development Status : Undisclosed
Sponsor : Hershey Medical Center | National Institute of Diabetes and Digestive and Kidney Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable